Tag: weight loss injections

Why has Injectable weight-loss drug Wegovy become popular?

Certainly! Here’s a more detailed explanation of why injectable weight-loss drug Wegovy has gained popularity. Wegovy’s chemical composition is semaglutide,:

Efficiency and Effectiveness: Wegovy has shown remarkable effectiveness in clinical trials. It belongs to a class of drugs called GLP-1 receptor agonists, which work by mimicking the effects of a naturally occurring hormone called glucagon-like peptide-1 (GLP-1). By activating GLP-1 receptors in the brain, Wegovy helps to regulate appetite and increase feelings of fullness, leading to reduced food intake and subsequent weight loss. Studies have demonstrated that individuals taking Wegovy, in combination with a reduced-calorie diet and increased physical activity, achieved significant weight loss compared to those on a placebo.

Long-term Benefits: Another reason for Wegovy’s popularity is its potential for long-term weight loss maintenance. Clinical trials have shown that individuals who continued using Wegovy after the initial weight loss phase were able to sustain their weight loss and even achieve further reduction over time. This long-term benefit is encouraging for those seeking sustainable weight management solutions.

Medical Supervision and Guidance: Since Wegovy is a prescription-only medication, its popularity may also be attributed to the confidence that comes with using a weight-loss drug under medical supervision. Healthcare professionals can closely monitor patient progress, provide guidance on lifestyle modifications, and ensure the drug’s compatibility with any existing health conditions or medications. This personalized approach enhances safety and promotes a more holistic approach to weight loss.

Positive Impact on Overall Health: Obesity is associated with a higher risk of developing various health conditions, including cardiovascular disease, type 2 diabetes, certain types of cancer, and joint problems. By aiding in weight reduction, Wegovy can potentially improve these health outcomes and reduce the risks associated with obesity-related conditions. The prospect of achieving better overall health is a significant factor driving the popularity of Wegovy.

Continued Research and Support: The popularity of Wegovy is also influenced by ongoing research and support from healthcare professionals. As scientific knowledge and understanding of the drug continue to expand, healthcare providers are becoming more confident in prescribing it as part of a comprehensive weight-management strategy.

Individualized Approach: While Wegovy has shown promising results, it is important to remember that weight loss is a complex issue, and individual experiences may vary. A personalized approach, consisting of a well-balanced diet, regular exercise, behavior modifications, and the guidance of healthcare professionals, is integral to achieving and maintaining weight loss.

It is worth noting that like any medication, Wegovy may have potential side effects and is not suitable for everyone. Therefore, consulting with a healthcare professional is essential to determine its appropriateness and potential benefits based on an individual’s specific circumstances.

Long-Term Side Effects of Ozempic

Ozempic (semaglutide) is a medication commonly prescribed to help manage type 2 diabetes. While it is generally considered safe and effective when used as directed, like any medication, it may have potential side effects. Here are some of the long-term side effects that have been reported with the use of Ozempic:

  1. Kidney Problems: In rare cases, Ozempic has been associated with kidney problems, including kidney failure. It’s important to monitor your kidney function regularly when taking this medication.
  2. Thyroid Cancer: There have been reports of thyroid cancer in animal studies with semaglutide, the active ingredient in Ozempic. However, no clear link has been established with humans at this time. As a precaution, it is recommended to inform your healthcare provider if you have a personal or family history of thyroid cancer before starting Ozempic.
  3. Pancreatitis: Although rare, pancreatitis (inflammation of the pancreas) has been reported with the use of Ozempic. Symptoms may include severe abdominal pain, nausea, and vomiting. Contact your doctor immediately if you experience these symptoms.
  4. Gallbladder Disease: Some individuals taking Ozempic may develop gallbladder-related problems, such as gallstones or inflammation of the gallbladder. Seek medical attention if you experience abdominal pain, especially if it is accompanied by fever or jaundice.
  5. Allergic Reactions: In rare cases, allergic reactions to Ozempic may occur. Symptoms can include rash, itching, swelling, severe dizziness, or difficulty breathing. If you experience any of these symptoms, seek immediate medical attention.

It is essential to discuss any concerns or potential side effects with your healthcare provider. They will be able to provide you with personalized information and guidance based on your specific health situation.

Saxenda Injection: is it An Effective Weight Loss Solution?

Saxenda is an injectable prescription medication that contains liraglutide as its active ingredient. It works by mimicking the effects of a hormone called glucagon-like peptide-1 (GLP-1), which regulates glucose and satiety in the body. Saxenda is intended to be used in conjunction with a reduced-calorie diet and increased physical activity for adults with a body mass index (BMI) of 30 or greater, or for those with a BMI of 27 or greater who have at least one weight-related medical condition, such as hypertension, type 2 diabetes, or high cholesterol.

According to clinical studies, Saxenda has been shown to be an effective weight loss solution. In a 56-week trial, participants who used Saxenda lost an average of 8.1% of their initial body weight, compared to an average of 2.8% for those who received a placebo. Another study found that participants who used Saxenda lost an average of 8.5 kg (18.7 lbs) over a 56-week period, compared to 2.3 kg (5.1 lbs) for those who received a placebo. Saxenda has been shown to improve not only weight loss but also other health markers, such as blood glucose levels and blood pressure, in people with obesity or overweight.

Although Saxenda appears to be a promising weight loss tool, it is important to note that it is not a magic bullet. Weight loss still requires a commitment to lifestyle changes, such as healthy eating habits and regular exercise. Saxenda also carries a risk of side effects, including nausea, diarrhea, vomiting, and constipation, and may interact with other medications. Therefore, it is important to discuss the potential benefits and risks of Saxenda with a healthcare provider before starting treatment.

Saxenda Injection side effects

When considering the use of Saxenda Injection, it is important to be aware of any potential side effects that may occur. These side effects can range from mild to severe and may vary depending on the individual’s health status and dosage amount.

 Some common side effects of Saxenda Injection include nausea, diarrhea, constipation, headache, and low blood sugar levels. It is crucial to monitor these symptoms closely and contact a healthcare provider if they persist or worsen over time.

In addition, more serious side effects such as pancreatitis and thyroid tumors have been reported in rare cases. Therefore, it is essential to discuss any concerns or questions about Saxenda Injection with a healthcare professional before starting treatment. By doing so, individuals can make informed decisions about their health and ensure that they receive the best possible care while using this medication.

How much weight can I lose using semaglutide ?

You can lose up to 15% of your starting body weight when using semaglutide in injections for weight loss (such as Ozempic). From 0.25 mg at the beginning to 2.4 mg once a week by week 16, the semaglutide dosage is gradually increased. In order to answer the question “how much weight can you lose with semaglutide,” researchers at the University of Liverpool created a study with very specific guidelines.

A group of 1961 adults was gathered who had a BMI that indicated obesity (>30). The average weight loss in those who received the semaglutide slimming injection was nearly 15% (as opposed to the placebo’s -2.4%). You can shed about 15 kg in 68 weeks by taking Ozempic or another medication along with semaglutide once per week (17 months).

Here are the precise weight loss results and advancements made by a group of almost 2,000 participants in a study released in 2021. Two research subgroups were created from the participant pool.


The first received a weekly slimming injection with semaglutide (the same substance found in, for example, Ozempic) starting at a dose of 0.25 mg to 2.4 mg, and received recommendations on how to lose weight through lifestyle changes.

  1. The first received a weekly slimming injection with semaglutide (the same substance found in, for example, Ozempic) starting at a dose of 0.25 mg to 2.4 mg, and received recommendations on how to lose weight through lifestyle changes.
  2. The second group of people received only recommendations regarding lifestyle changes for effective weight loss.

Weight loss with semaglutide slimming injections (e.g. Ozempic) progressed as follows:

  • 1st month (4 weeks) of slimming injections – approx. -2.5% of the initial body weight (a person weighing 100 kg loses 2.5 kg);
  • 2nd month (8 weeks) of slimming injections – approx. -4% of the initial body weight (a person weighing 100 kg loses approx. 4 kg);
  • 3rd month (12 weeks) of slimming injections – approx. -6% of the initial body weight (a person weighing 100 kg loses approx. 6 kg);
  • 4th month (16 weeks) of slimming injections – approx. -8% of the initial body weight (a person weighing 100 kg loses approx. 8 kg);
  • 5th month (20 weeks) of slimming injections – approx. -9.5% of the initial body weight (a person weighing 100 kg loses approx. 9.5 kg);

After the fifth month of taking slimming injections, you can still lose weight effectively, but the pace of weight loss is noticeably slowing down:

  • 7th month (28 weeks) of slimming injections – approx. -11.5% of the initial body weight (a person weighing 100 kg loses approx. 11.5 kg);
  • 9th month (36 weeks) of slimming injections – approx. -13% of the initial body weight (a person weighing 100 kg loses approx. 13 kg);
  • 11th month (44 weeks) of slimming injections – approx. -14.8% of the initial body weight (a person weighing 100 kg loses approx. 14.8 kg);
  • 13th month (52 weeks) of slimming injections – approx. -15.8% of the initial body weight (a person weighing 100 kg loses approx. 15.8 kg);
  • 15th month (60 weeks) of slimming injections – approx. 14.9% of the initial body weight (a person weighing 100 kg loses approx. 14.9 kg).

But more than just the average weight loss is remarkable. Even more amazing is the difference in the number of people who benefited from slimming injections versus those who benefited from dietary advice alone. When taking semaglutide injections once a week, as many as 86.4% of participants actually lost weight, as opposed to 31.5% of participants who lost weight only after being given advice (without injections). The following table displays the precise data:

Weight Loss/InterventionWeight loss injection once a week – semaglutide (e.g. Ozempic)Nutrition education and lifestyle change (placebo)
Weight loss of 5% or more compared to your starting weight86.4% of people joining the study (1047 people from the study)31.5% of people joining the study (182 people)
Weight loss of 10% or more compared to your starting weight69.1% of people joining the study (838 people from the study)12% of people joining the study (69)
Weight loss of 15% or more compared to your starting weight50.5% (612 people from the study)4.9% of people joining the study (28)

The table clearly shows that injecting semaglutide resulted in much more effective weight loss than just changing eating habits.

Works Cited

“Zastrzyki Na Odchudzanie – Ile Można Schudnąć? – Polki.pl.” Polki.pl, 24 Jan. 2023, polki.pl/dieta-i-fitness/odchudzanie,zastrzyki-na-odchudzanie-ile-mozna-schudnac-spodziewane-efekty,10448926,artykul.html.

Don’t combine popular weight loss injections with other drugs

This case demonstrates how dangerous it can be to combine popular “weight loss injections” with other drugs. A young woman who was prescribed weight-loss medication nearly died as a result of dangerous complications. Doctors warn that taking too many drugs can result in dangerous organ damage.

A patient was prescribed  semaglutide, one of the most recently popular prescription drugs for weight loss. When combined with other drugs, the therapy proved to be a lethal threat. Doctors refer to this phenomenon as polypragmasia, which refers to multi-drug therapy, the side effects of which frequently outweigh the therapeutic effect.

Therapy with “injections for slimming” led almost to a tragedy

There were media reports about a 29-year-old patient at an obesity treatment clinic who experienced dangerous side effects from the therapy. The woman was given the popular injectable semaglutide as well as the antidepressant and antiemetic combination drug bupropion+naltrexone, which is used to treat obesity. Her weight was dropping, but not due to the therapeutic effect of the prescribed medications, but due to the debilitating effect of the incorrect treatment on the body.

The patient developed infection-like symptoms (fever, sweats, chills) after 14 days of treatment that did not improve with antipyretics. She was then admitted to the intensive care unit due to potentially fatal complications. Renal failure and serotonin syndrome were diagnosed by doctors. Fortunately, it was discovered that the woman’s medications caused dangerous interactions and side effects. The patient’s life was saved. However, the story could have ended differently.

Beware of drug combinations with ‘weight loss injections

Semaglutide and other drugs in the GLP-1 analogue class, also known as slimming injections, have recently gained popularity due to their weight-loss properties. They can, however, interfere with drug absorption. Semaglutide slows stomach emptying, affecting the rate at which other substances are absorbed. As a result, people who take medications should exercise caution and keep in mind that they may experience side effects. Although it should be noted that the 29-year-old patient’s dangerous condition was caused by the interaction of other drugs as well.

Polypharmacy is becoming an increasingly common problem, according to experts. It usually involves elderly people who are often afflicted with multiple diseases and to whom doctors from various specialties prescribe drugs without comprehensive treatment coordination. Excessive use is caused by the patient’s lack of knowledge about the other pharmacological agents he or she is taking. As a result, therapy may be more harmful than beneficial. As a result, raising patient awareness of the issue is critical. It’s always a good idea to tell your doctor about any medications you’re taking (even if he doesn’t ask) and to report any troubling symptoms as soon as possible.

“Młoda Kobieta Przyjmowała Zastrzyki Na Odchudzanie. Omal Nie Przypłaciła Leczenia Życiem – Polki.pl.” Polki.pl, 3 Mar. 2023, stylzycia.polki.pl/leki,mloda-kobieta-brala-popularne-zastrzyki-na-odchudzanie-prawie-zmarla,10449736,artykul.html.